Noodles & Company Prices Offering at $39.50 Per Share

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Noodles & Company Prices Offering at $39.50 Per Share

BROOMFIELD, Colo., Dec. 5, 2013 (GLOBE NEWSWIRE) -- Noodles & Company (Nasdaq: NDLS ) today announced the pricing of its primary and secondary offering by the Company and selling stockholders of 4,500,000 shares of Class A common stock at a price of $39.50 per share. Noodles & Company also expects to enter into an agreement with certain officers of Noodles & Company to repurchase shares of Class A common stock directly from such officers in a private, non-underwritten transaction at a price per share equal to the net proceeds per share that Noodles & Company and the selling stockholders receive in the offering. Noodles & Company will use the proceeds from the offering to fund the repurchase.

Morgan Stanley & Co. LLC and UBS Securities LLC are acting as joint book-running managers and representatives of the underwriters for the offering. Jefferies LLC, BofA Merrill Lynch, Piper Jaffray & Co., Robert W. Baird & Co. Incorporated and RBC Capital Markets, LLC are acting as book-running managers. For up to 30 days, the Company and the selling stockholders have granted the underwriters the right to purchase up to an additional 675,000 shares of common stock to cover over-allotments.

The registration statement for Noodles & Company relating to these securities was declared effective by the Securities and Exchange Commission on December 5, 2013. This press release shall not constitute an offer to sell or a solicitation of an offer to buy, and there shall not be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

Any offer or sale will be made only by means of a written prospectus forming part of the effective registration statement. A copy of the final prospectus relating to these securities may be obtained, when available, from Morgan Stanley & Co. LLC at 180 Varick Street, 2 nd Floor, New York, New York 10014, Attention: Prospectus Department or from UBS Securities LLC at 299 Park Avenue, New York, New York 10171.

About Noodles & Company

Founded in 1995, Noodles & Company is a fast-casual restaurant chain that serves classic noodle and pasta dishes from around the world with 372 locations system-wide in 29 states and the District of Columbia as of November 15, 2013. Known as Your World Kitchen, Noodles & Company's globally inspired menu consists of more than 25 fresh, customizable noodle bowls, salads, soups and sandwiches that are prepared quickly using quality ingredients. From healthy to indulgent, spicy to comforting, the menu provides favorites for everyone from kids to adults. Popular dishes include the spicy Indonesian Peanut Saute, Med Salad with naturally raised pork and creamy Wisconsin Mac & Cheese.

Media Contact: Kristina Jorge (646) 277-1234 Investor Relations:

Scroll down for more posts ▼

Top 10 Most Recent News Articles

CSL Names Deborah Waterhouse as CEO in Strategic Move

Updated Category News Views 8

A Key Transition: Deborah Waterhouse Takes the Helm In a move that's sure to jolt the biopharma sphere, CSL Limited just handed the CEO reins over to Deborah Waterhouse. Set to start officially on February 1, 2027, this strategic appointment seems well plotted after a diligent global hunt by CSL's board for someone who can drive their enterprise into its next surge of...

Continue Reading
Bolt Teams with NVIDIA for Europe AV Expansion

Updated Category News Views 2

Racing Towards an Autonomous Future Well, hold onto your seats because the European roads will soon witness one hell of a technological trip—with an autonomous twist. Bolt, in cahoots with NVIDIA and Lucid, is plotting to roll out a massive fleet of autonomous vehicles just gearing up to hit the streets. The project's kicking off in Madrid in 2027 and aims to sprinkle...

Continue Reading
Ashford Hospitality Trust: Fee Waiver and Share Buyback

Updated Category News Views 3

Strategic Moves in a Challenging Market When it rains, it pours. Ashford Hospitality Trust (NYSE: AHT), the real estate investment trust that's got its fingers in the hotel industry pie, is shaking things up with some bold maneuvers. The company just dropped a bombshell: it's waiving a $17 million advisory fee, buying back shares, and terminating its at-the-market (ATM)...

Continue Reading
Hyliion Legal Woes Shake Investor Confidence

Updated Category News Views 9

Legal Storm Brews Over Hyliion Investments If you think riding the stock market is like sailing a calm sea, wake up. Hyliion Holdings Corp. (NYSE:HYLN) finds itself steaming headlong into rough waters. A securities class action lawsuit, Olmeta v. Hyliion Holdings Corp., accuses the company of embellishing its ambitions. The lawsuit cites potential wrongdoing in a...

Continue Reading
Partner Climbs 25 Spots on ENR's Environmental Firm List

Updated Category News Views 11

A Leap Forward in Environmental Expertise Alright, folks, let's dive into some real grit. Partner Engineering and Science, Inc. has pulled off a neat little trick. They've jumped up 25 spots on the 2026 Engineering News-Record's Top 200 Environmental Firms list. They’ve been making this list for 14 years straight, and that's no fluke. It's a hard road, especially when...

Continue Reading
Network Brainiacs Expands Footprint into Maryland Market

Updated Category News Views 10

Network Brainiacs Steps into Maryland Territory If you're in the tech services game, expansion stories are the bread and butter of this business. Network Brainiacs, a seasoned veteran in the managed IT and cybersecurity sectors, has taken their first big step into Maryland by acquiring Computer Enhancement Systems (CES), a notable player in the field, as of September 1,...

Continue Reading
Glint: Lovense's New Era in Intimacy Tech

Updated Category News Views 6

From Thrill to Touch: The Glint Debut Screw the traditional remote control for sex toys! Lovense is straight up flipping the script with Glint. This isn't about adding more buttons or connecting another app. We're talking about a butt plug that lets your partner's thrust set the whole vibe. Forget fumbling with phones in the heat of the moment—this toy syncs your...

Continue Reading
Millrose Investors Face Unveiling of Financial Missteps

Updated Category News Views 11

A Cold Shower for Millrose Properties' Investors Investing in Millrose Properties, Inc. (NYSE: MRP) didn't quite pan out as some folks hoped. On the heels of Hunterbrook's report about dubious deals, the Company's stock tumbled 8.53%, smacking investors with a not-so-gentle reminder of market realities. Sure, stocks can dip and dive like a rollercoaster, but when it...

Continue Reading
Oberndorf, Bascom Snap Up San Jose Flats for $53M

Updated Category News Views 11

Well, isn’t this just a spicy tidbit from the real estate frontier? Oberndorf Real Estate Management and The Bascom Group are strutting into San Jose with a hefty $53.1 million deal that snags them the Museum Park Apartments. These guys aren't just dipping their toes; they’re cannonballing into the market with style. Now, exactly what does it mean for you and me?...

Continue Reading
Papa John's Legal Woes: Class Action Lawsuit Hits Hard

Updated Category News Views 6

A Hot Slice of Legal Trouble for Papa John's Ah, what a steaming mess Papa John's seems to have landed in! And not the good kind with extra cheese. The lawsuit bell tolls for them, reminding investors that even the big guys can get burned. This time, it's for allegedly not having their story straight when it came to market expectations and promotional tactics. Under the...

Continue Reading

Top 5 Most Recently Viewed Articles

Rancho Mission Viejo: Leading the Way in Wellness Real Estate

Updated Category News Views 202

Rancho Mission Viejo Recognized Globally for Wellness Development The Ranch stands out as a model for wellness communities and showcases the impact on individual lives. This 23,000-acre master-planned community and functional cattle ranch has achieved global recognition as one of the largest intentional wellness real estate developments. A Testament to Community Design As...

Continue Reading
Revolutionizing Patient Access with AI: The New Trial Finder

Updated Category News Views 177

Introducing the Future of Clinical Trials The world of radiopharmaceuticals is changing rapidly, with an innovative new tool set to revolutionize the way patients and healthcare providers access critical information about clinical trials. The Radiopharmaceutical Trial Finder, backed by the ICPO Foundation, was developed through a collaboration between WARMTH and...

Continue Reading
Semler Scientific Faces Legal Challenges Amid Controversy

Updated Category News Views 157

Semler Scientific Under Legal Scrutiny Semler Scientific, Inc. is currently facing a class action lawsuit that sheds light on serious allegations regarding their securities practices. Shareholders of the company, identified by the ticker SMLR, are encouraged to be proactive amidst these developments. The lawsuit primarily alleges violations of federal securities exchanges...

Continue Reading
Charles Dayoub Joins The Willis Law Group Fraud Team

Updated Category News Views 207

Charles Dayoub Enhances The Willis Law Group’s Fraud Team We are delighted to announce that Charles Dayoub has joined The Willis Law Group P.L.L.C., bringing with him a wealth of experience with over 18 years in law and extensive expertise in executive positions. His previous role at a prominent law firm involved dealing with government receivables and regulatory...

Continue Reading
Evaluating Revolution Medicines' Future Potential and Progress

Updated Category News Views 168

Revolution Medicines Maintains Positive Outlook Piper Sandler has sustained an optimistic outlook regarding Revolution Medicines (NASDAQ: RVMD), reaffirming its Overweight rating with a specified price target of $57.00. This commitment to the stock's rating comes after recent developments linked to the company’s Phase I trial, which is focused on RMC-6236, a potential...

Continue Reading